News
Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...
Patients express mixed feelings about AI in healthcare, favoring its use for documentation and administrative tasks while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results